Participants Panelists eligible for participation in the study met the following selection criteria: they were specialists in endocrinology, family and community medicine, internal medicine, or cardiology, with at least 2 years of experience managing people with T2D and high CV risk or established CVD, and practicing in the public healthcare setting in Spain
The appropriate choice depends on the patients BMI, health history, previous treatment response, goals, and long-term preferences
CrossRef Adipokines, immunity, and infection Shashvat Joshi, Aryan Patel, Rayhan Raja, Kartik N Rajagopalan Endocrinology.2026;[Epub] CrossRef Serum resistin as a potential biomarker for stratifying the severity of coronary heart disease: a network meta-analysis Yicheng Ling, Mengyao Wei, Jiapeng Luo, Tianxiang Gu, Xuan Jiang Frontiers in Cardiovascular Medicine.2026;[Epub] CrossRef Blood DNA methylation of EIF5A and TGIF1 is associated with adipose tissue health and metabolic outcomes in obesity: a multi-cohort study Sophie Ruf, Anne Hoffmann, Luise Mller, Kathrin Landgraf, Mandy Vogel, Emil Jrsboe, Phil Kubitz, Arne Dietrich, Adhideb Ghosh, Falko No, Christian Wolfrum, Melina Claussnitzer, Hans Hauner, Michael Stumvoll, Ronny Baber, Matthias Blher, Antje Krner, Clinical Epigenetics.2026;[Epub] CrossRef Neutrophil extracellular traps drive cholangiocyte injury via ZNF709TP53MDM2 pathway in primary biliary cholangitis Mingxin Su, Zhenfeng Tian, Miao Yu, Enlai Huang, Jinjian Liang, Bingrong Hu, Yinting Chen Hepatology International.2026;[Epub] CrossRef Impaired mitochondrial flexibility hinders fat pad remodeling in obese mice after 24 h of fasting Mariele Lino Silva, Laura dos Santos Fernandes, Joyce Elisa Heredia, Amanda Carla Clemente de Oliveira, Adma Maciel Babetto, Gustavo de Oliveira Zanetti, Dawit Albieiro Pinheiro Gonalves, Mauro Martins Teixeira, Genevive Marcelin, Marina Chaves de Olive Life Sciences.2026
That clinical evidence underpins both the drug's value proposition and the price Novo Nordisk has maintained
Coronary tracer uptake decreased significantly in the liraglutide arm (assessed as both maximum and mean-of-maximum standardized uptake values) at the participant level and the individual coronary-segment level
Published research by Bowers et al
